277 related articles for article (PubMed ID: 353658)
1. [Study of the bleeding mechanism during fibrinolysis induced by streptokinase in the rabbit (author's transl)].
Bara L; Samama M; Bilski-Pasquier G; Bloch MF; Rochas S
Pathol Biol (Paris); 1977 Dec; 25 Suppl():48-54. PubMed ID: 353658
[TBL] [Abstract][Full Text] [Related]
2. In vitro effects of bencyclan on coagulation, fibrinolysis and platelet function.
Ponari O; Civardi E; Dettori G; Magha A; Potì R; Bulletti G
Arzneimittelforschung; 1976; 26(8):1532-8. PubMed ID: 12770
[TBL] [Abstract][Full Text] [Related]
3. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ
Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
[TBL] [Abstract][Full Text] [Related]
4. Rapid dissociation of platelet-rich fibrin clots in vitro by a combination of plasminogen activators and antiplatelet agents.
Lam SC; Dieter JP; Strebel LC; Taylor TM; Muscolino G; Feinberg H; Le Breton GC
J Pharmacol Exp Ther; 1991 Dec; 259(3):1371-8. PubMed ID: 1762085
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo functions of thrombin-treated platelets.
Reimers HJ; Kinlough-Rathbone RL; Cazenave JP; Senyi AF; Hirsh J; Packham MA; Mustard JF
Thromb Haemost; 1976 Feb; 35(1):151-66. PubMed ID: 785686
[TBL] [Abstract][Full Text] [Related]
6. Assessment of antithrombotic properties of sodium ibuprofen.
Esquivel CO; Bergqvist D; Björck CG; Carson SN; Nilsson B
Thromb Haemost; 1982 Aug; 48(1):87-90. PubMed ID: 7135348
[TBL] [Abstract][Full Text] [Related]
7. Effects of suprofen, an inhibitor of prostaglandin biosynthesis, on platelet function, plasma coagulation and fibrinolysis II. In vivo experiments.
De Clerck F; Vermylen J; Reneman R
Arch Int Pharmacodyn Ther; 1975 Sep; 217(1):68-79. PubMed ID: 1190914
[TBL] [Abstract][Full Text] [Related]
8. [Influence on haemostasis exercised by Prostaglandin F2alpha in missed abortion (author's transl)].
Briel RC; Kunz S; Kidess E
Geburtshilfe Frauenheilkd; 1978 Oct; 38(10):862-7. PubMed ID: 700348
[TBL] [Abstract][Full Text] [Related]
9. Clotting and fibrinolysis.
Prentice CR
J Clin Pathol Suppl (R Coll Pathol); 1975; 9():50-3. PubMed ID: 182726
[No Abstract] [Full Text] [Related]
10. Patho-physiological studies on lactic acid-induced pulmonary thrombosis in rat. I. Effect of heparin, acetylsalicylic acid, urokinase and tranexamic acid.
Tomikawa M
Thromb Diath Haemorrh; 1975 Sep; 34(1):145-58. PubMed ID: 1188708
[TBL] [Abstract][Full Text] [Related]
11. Comparative effects of recombinant staphylokinase and streptokinase on platelet aggregation.
Abdelouahed M; Hatmi M; Helft G; Emadi S; Elalamy I; Samama MM
Thromb Haemost; 1997 May; 77(5):815-7. PubMed ID: 9184383
[TBL] [Abstract][Full Text] [Related]
12. The thrombolytic activity of streptokinase in the rabbit.
English PD; Smith RA; Dupe RJ; Green J; Hibbs MJ
Thromb Haemost; 1981 Aug; 46(2):535-7. PubMed ID: 7302893
[TBL] [Abstract][Full Text] [Related]
13. [Changes of platelet function, coagulation and fibrinolysis during induction of labour at term by prostaglandin F2alpha and oxytocin (author's transl)].
Briel RC; Kidess E; Kunz S
Z Geburtshilfe Perinatol; 1978 Jun; 182(3):238-42. PubMed ID: 80063
[TBL] [Abstract][Full Text] [Related]
14. Concentration effects of platelets, fibrinogen and thrombin on platelet aggregation and fibrin clotting.
Chao FC; Tullis JL; Kenney DM; Conneely GS; Doyle JR
Thromb Diath Haemorrh; 1974 Sep; 32(1):216-31. PubMed ID: 4454041
[TBL] [Abstract][Full Text] [Related]
15. Aprotinin protects platelets against the initial effect of cardiopulmonary bypass.
van Oeveren W; Harder MP; Roozendaal KJ; Eijsman L; Wildevuur CR
J Thorac Cardiovasc Surg; 1990 May; 99(5):788-96; discussion 796-7. PubMed ID: 1691806
[TBL] [Abstract][Full Text] [Related]
16. [Systemic effects of thrombolytic therapy].
Balduini CL; Gamba G; Bertolino G; Noris P; Previtali M; Ascari E
Haematologica; 1991 Jun; 76 Suppl 3():281-90. PubMed ID: 1752524
[No Abstract] [Full Text] [Related]
17. Anti-thrombotic effects and bleeding risk of AJvW-2, a monoclonal antibody against human von Willebrand factor.
Kageyama S; Yamamoto H; Nagano M; Arisaka H; Kayahara T; Yoshimoto R
Br J Pharmacol; 1997 Sep; 122(1):165-71. PubMed ID: 9298543
[TBL] [Abstract][Full Text] [Related]
18. Pathophysiology and clinical aspects of fibrinolysis and inhibition of coagulation. Experimental and clinical studies with special reference to women on oral contraceptives and selected groups of thrombosis prone patients.
Jespersen J
Dan Med Bull; 1988 Feb; 35(1):1-33. PubMed ID: 3277796
[TBL] [Abstract][Full Text] [Related]
19. Fibrinogen degradation products in plasma following induced hyperfibrinolysis.
Chek JB; Panchenko NI
East Afr Med J; 2000 Apr; 77(4):217-20. PubMed ID: 12858907
[TBL] [Abstract][Full Text] [Related]
20. Plasmin-induced platelet aggregation and platelet release reaction. Effects on hemostasis.
Niewiarowski S; Senyi AF; Gillies P
J Clin Invest; 1973 Jul; 52(7):1647-59. PubMed ID: 4268896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
